Pulse pressure is independently associated with sensorimotor peripheral neuropathy in patients with type 2 diabetes

Journal of Internal Medicine

Volumn 258, Issue 1, 2005, Pages 38-44

  Jarmuzewska, E A ^a   Mangoni, A A ^b,c  

^a UNIVERSITY OF MILAN   (Italy)

^b FLINDERS UNIVERSITY   (Australia)

^c FLINDERS UNIVERSITY   (Australia)

Author keywords

Diabetes; Hypertension; Neuropathy

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; COMORBIDITY; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NERVE FUNCTION; NEUROPHYSIOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL NEUROPATHY; PERONEUS NERVE; PRIORITY JOURNAL; PULSE PRESSURE; SENSORIMOTOR FUNCTION;

AGE FACTORS; ANALYSIS OF VARIANCE; AUTONOMIC NERVOUS SYSTEM DISEASES; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURAL CONDUCTION; PERIPHERAL NERVOUS SYSTEM DISEASES; PERONEAL NERVE; SURAL NERVE; TIBIAL NERVE; ULNAR NERVE;

EID: 21344433691     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2005.01500.x     Document Type: Article

References (34)

1. Vinik AI, Park TS, Stansberry KB, Pittenger GL. Diabetic neuropathies. Diabetologia 2000; 43: 957-73.
2. Harris M, Eastman R, Cowie C. Symptoms of sensory neuropathy in adults with NIDDM in the U.S. population. Diabetes Care 1993; 16: 1446-52.
3. Cohen JA, Jeffers BW, Faldut D, Marcoux M, Schrier RW. Risks for sensorimotor peripheral neuropathy and autonomic neuropathy in non-insulin-dependent diabetes mellitus (NIDDM). Muscle Nerve 1998; 21: 72-80.
4. Dyck PJ, Kratz KM, Karnes JL et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993; 43: 817-24.
5. Martyn CN, Hughes RA. Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry 1997; 62: 310-8.
6. Malik RA. Can diabetic neuropathy be prevented by angiotensin-converting enzyme inhibitors? Ann Med 2000; 32: 1-5.
7. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-53.
8. Diabetes Control and Complications Trial (DCCT) Research Group. Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial. Ann Neurol 1995; 38: 869-80.
9. Cameron NE, Eaton SE, Cotter MA, Tesfaye S. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 2001; 44: 1973-88.
10. Ziegler D, Sohr CG, Nourooz-Zadeh J. Oxidative stress and antioxidant defense in relation to the severity of diabetic polyneuropathy and cardiovascular autonomie neuropathy. Diabetes Care 2004; 27: 2178-83.
11. Sands ML, Shetterly SM, Franklin GM, Hamman RF. Incidence of distal symmetric (sensory) neuropathy in NIDDM. The San Luis Valley Diabetes Study. Diabetes Care 1997; 20: 322-9.
12. Valensi P, Giroux C, Seeboth-Ghalayini B, Attali JR. Diabetic peripheral neuropathy: effects of age, duration of diabetes, glycemic control, and vascular factors. J Diabetes Complications 1997; 11: 27-34.
13. Zarrelli MM, Amoruso L, Beghi E, Apollo F, Di Viesti P, Simone P. Arterial hypertension as a risk factor for chronic symmetric polyneuropathy. J Epidemiol Biostat 2001; 6: 409-13.
14. Benetos A, Zureik M, Morcet J et al. A decrease in diastolic blood pressure combined with an increase in systolic blood pressure is associated with a higher cardiovascular mortality in men. J Am Coll Cardiol 2000; 35: 673-80.
15. Domanski M, Norman J, Wolz M, Mitchell G, Pfeffer M. Cardiovascular risk assessment using pulse pressure in the first national health and nutrition examination survey (NHANES I). Hypertension 2001; 38: 793-7.
16. Miwa Y, Tsushima M, Arima H, Kawano Y, Sasaguri T. Pulse pressure is an independent predictor for the progression of aortic wall calcification in patients with controlled hyperlipidemia. Hypertension 2004; 43: 536-40.
17. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1994; 17: 1281-9.
18. American Diabetes Association. American Academy of Neurology. Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Electrodiagnostic measures. Muscle Nerve 1992; 15: 1150-4.
19. Dyck PJ. Detection, characterization, and staging of polyneuropathy: assessed in diabetics. Muscle Nerve 1988; 11: 21-32.
20. Trojaborg W. The electrophysiologic profile of diabetic neuropathy. Semin Neurol 1996; 16: 123-8.
21. Ewing DJ, Clarke BF. Diagnosis and management of diabetic autonomic neuropathy. Br Med J (Clin Res Ed) 1982; 285: 916-8.
22. Guidelines Committee. European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-53.
23. Ibrahim S, Harris ND, Radatz M et al. A new minimally invasive technique to show nerve ischaemia in diabetic neuropathy. Diabetologia 1999; 42: 737-42.
24. Tesfaye S, Harris N, Jakubowski JJ et al. Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a novel technique of nerve photography and fluorescein angiography. Diabetologia 1993; 36: 1266-74.
25. Giannini C, Dyck PJ. Basement membrane reduplication and pericyte degeneration precede development of diabetic polyneuropathy and are associated with its severity. Ann Neurol 1995; 37: 498-504.
26. Malik RA, Newrick PG, Sharma AK et al. Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy. Diabetologia 1989; 32: 92-102.
27. Yasuda H, Dyck PJ. Abnormalities of endoneurial microvessels and sural nerve pathology in diabetic neuropathy. Neurology 1987; 37: 20-8.
28. Benetos A, Rudnichi A, Safar M, Guize L. Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects. Hypertension 1998; 32: 560-4.
29. Benetos A, Safar M, Rudnichi A et al. Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension 1997; 30: 1410-5.
30. Mangoni AA. Diastolic and pulse pressure: the old and the new? Hypertension 2004; 43: 531-2.
31. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-13.
32. Reja A, Tesfaye S, Harris ND, Ward JD. Is ACE inhibition with lisinopril helpful in diabetic neuropathy. Diabet Med 1995; 12: 307-9.
33. Malik RA, Williamson S, Abbott C et al. Effect of angiotensin-converting- enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial. Lancet 1998; 352: 1978-81.
34. Hotta N, Nakamura J, Sumita Y. Effects of the 5-HT2A receptor antagonist sarpogrelate in diabetic neuropathy. A pilot study. Clin Drug Invest 1999; 18: 199-207.